phencyclidine has been researched along with Parkinson Disease, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchet, JP; Ceulemans, E; Lauwerys, R; Magos, C; Roels, H | 1 |
| Backlund, EO; Gerhardt, G; Hoffer, B; Lindvall, O; Olson, L; Rose, G; Seiger, A; Strömberg, I | 1 |
2 other study(ies) available for phencyclidine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Urinary excretion of homovanillic acid in workers exposed to manganese.
Topics: Adult; Dust; Environmental Monitoring; Homovanillic Acid; Humans; Male; Manganese; Maximum Allowable Concentration; Middle Aged; Occupational Diseases; Occupational Exposure; Parkinson Disease, Secondary; Risk Factors | 1993 |
Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenal Medulla; Animals; Caudate Nucleus; Chromaffin System; Disease Models, Animal; Dopamine; Humans; Nerve Regeneration; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Phencyclidine; Pyridines; Receptors, Dopamine; Substantia Nigra; Synaptic Transmission | 1987 |